Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients

Victoria Merrick,Kajal Mortier,Linda J. Williams,Rafeeq Muhammed,Marcus Auth,Mamoun Elawad,John Fell,Robert Mark Beattie,S Loganathan,F. Torrente,Mary-Anne Morris,Charles Charlton,Nicholas M. Croft,Astor Rodrigues,Mark Furman,Babu Vadamalayan,Huw R Jenkins,Veena Zamvar,Sally G. Mitton,Sonny K. F. Chong,Mike Cosgrove,Anthony K Akobeng,David C. Wilson,Richard K. Russell

Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients

2018

ABSTRACTObjective:The aim of this study was to measure the effectiveness, safety, and use of anti-tumor necrosis Factor (TNF) therapy in pediatric inflammatory bowel disease in the United Kingdom (UK).Methods:Prospective UK audit of patients newly starting anti-TNF therapy. Disease severity was asse

Keywords:

Tumor necrosis factor alpha
Diabetes mellitus
Disease
Endocrinology
Inflammatory bowel disease
Internal medicine
Medicine
Necrosis
disease severity
anti tumor necrosis factor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations